KURA ONCOLOGY, INC. (KURA)

13.25USD +0.76% (+0.10)

Over 1M: +38.5%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

10 12
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Free Cash Flow: -29M Q4 '23 — Free Cash Flow: -34.3M Q1 '24 — Operating Income: -54.5M Q1 '24 — Free Cash Flow: -48.9M Q2 '24 — Operating Income: -56.4M Q2 '24 — Free Cash Flow: -42.5M Q3 '24 — Operating Income: -59.9M Q3 '24 — Free Cash Flow: -43.4M Q4 '24 — Operating Income: -22.5M Q4 '24 — Free Cash Flow: 268.8M Q1 '25 — Revenue: 14.1M Q1 '25 — Operating Income: -64.7M Q1 '25 — Free Cash Flow: -72.2M Q2 '25 — Revenue: 15.3M Q2 '25 — Operating Income: -72.7M Q2 '25 — Free Cash Flow: -30.2M Q3 '25 — Revenue: 20.8M Q3 '25 — Operating Income: -80M Q3 '25 — Free Cash Flow: -83.2M Q4 '25 — Revenue: 17.3M Q4 '25 — Operating Income: -86.3M Q4 '25 — Free Cash Flow: 115M Q1 '26 — Revenue: 18.3M Q1 '26 — Operating Income: -78.8M Q1 '26 — Free Cash Flow: -86M Q2 '26 — Revenue: 20.9M Q2 '26 — Operating Income: -73M Q2 '26 — Free Cash Flow: -63.2M -80M 0 80M 160M 240M 320M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Income Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 50.4%
OE margin -202.5%
Oper. margin -411.9%
Accruals -31.5%
Gross margin 99.3%
EBITDA margin -410.2%
FCF margin -152.1%
OCF margin -144.7%
Profit margin -384.3%
ROA -50.5%
ROCE -67.7%
ROE -612.8%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.4
EV/Sales 8.7×
EV/OE -4.3×
P/C 2.3×
FCF yield -10.0%
P/B 24.3×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

10.0
RPO / sales 0.72×
RPO growth —
Segment HHI —

1 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.8
ND/EBITDA 0.75
Interest cover -224.0×
Cash / Debt 37.3×
Debt payback 0.0 yr
Quick ratio 4.7×
Cash runway 4.3 yr
Debt / Eq 0.29×
F-score 2.2 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales Q/Q +36.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales/sh Y/Y —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.